Bacterial pathogens and in-hospital mortality in revision surgery for periprosthetic joint infection of the hip and knee: analysis of 346 patients

被引:7
作者
Migliorini, Filippo [1 ,2 ]
Weber, Christian David [1 ]
Bell, Andreas [2 ]
Betsch, Marcel [3 ]
Maffulli, Nicola [4 ,5 ,6 ]
Poth, Vanessa [1 ]
Hofmann, Ulf Krister [1 ]
Hildebrand, Frank [1 ]
Driessen, Arne [1 ]
机构
[1] RWTH Univ Hosp, Dept Orthopaed Trauma & Reconstruct Surg, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Eifelklin St Brigida, Dept Orthopaed & Trauma Surg, D-52152 Simmerath, Germany
[3] Univ Hosp Erlangen, Dept Orthopaed & Trauma Surg, D-91054 Erlangen, Germany
[4] Univ Salerno, Dept Med Surg & Dent, I-84081 Baronissi, Italy
[5] Keele Univ, Fac Med, Sch Pharm & Bioengn, Stoke On Trent ST4 7QB, England
[6] Queen Mary Univ London, Mile End Hosp, Ctr Sports & Exercise Med, Barts & London Sch Med & Dent, 275 Bancroft Rd, London E1 4DG, England
关键词
Arthroplasty; Pathogens; Mortality; Knee; Hip; Infection; ARTHROPLASTY; FAILURE; MICROBIOLOGY; EPIDEMIOLOGY; GUIDELINES; PREDICTORS; BIOFILM;
D O I
10.1186/s40001-023-01138-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IntroductionThe management of periprosthetic joint infections (PJI) of the lower limb is challenging, and evidence-based recommendations are lacking. The present clinical investigation characterized the pathogens diagnosed in patients who underwent revision surgery for PJI of total hip arthroplasty (THA) and total knee arthroplasty (TKA).MethodsThe present study follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). The institutional databases of the RWTH University Medical Centre of Aachen, Germany, were accessed. The OPS (operation and procedure codes) 5-823 and 5-821 and the ICD (International Statistical Classification of Diseases and Related Health Problems) codes T84.5, T84.7 or T84.8 were used. All patients with PJI of a previous THA and TKA who underwent revision surgery were retrieved and included for analysis.ResultsData from 346 patients were collected (181 THAs and 165 TKAs). 44% (152 of 346 patients) were women. Overall, the mean age at operation was 67.8 years, and the mean BMI was 29.2 kg/m2. The mean hospitalization length was 23.5 days. 38% (132 of 346) of patients presented a recurrent infection.ConclusionPJI remain a frequent cause for revisions after total hip and knee arthroplasty. Preoperative synovial fluid aspiration was positive in 37%, intraoperative microbiology was positive in 85%, and bacteraemia was present in 17% of patients. Septic shock was the major cause of in-hospital mortality. The most common cultured pathogens were Staph. epidermidis, Staph. aureus, Enterococcus faecalis, and Methicillin-resistant Staph aureus (MRSA). An improved understanding of PJI pathogens is important to plan treatment strategies and guide the choice of empirical antibiotic regimens in patients presenting with septic THAs and TKAs.Level of Evidence: Level III, retrospective cohort study.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Risk of Prosthetic Joint Infection Increases Following Early Aseptic Revision Surgery of Total Hip and Knee Arthroplasty
    Quinlan, Nicole D.
    Werner, Brian C.
    Brown, Thomas E.
    Browne, James A.
    JOURNAL OF ARTHROPLASTY, 2020, 35 (12) : 3661 - 3667
  • [32] Retrospective Study from a Single Center to Identify Risk Factors Associated with Reinfection in Patients Undergoing 2-Stage Revision Surgery for Periprosthetic Joint Infection
    Zhang, Bingshi
    Liu, Zeming
    Liu, Sikai
    Liu, Bo
    Li, Mengnan
    Li, Wenao
    Han, Yongtai
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [33] Increased short- and long-term mortality amongst patients with early periprosthetic knee joint infection
    Olof Thompson
    Annette W-Dahl
    Anna Stefánsdóttir
    BMC Musculoskeletal Disorders, 23
  • [34] A break-even analysis of tranexamic acid for prevention of periprosthetic joint infection following total hip and knee arthroplasty
    Kolin, David A.
    Moverman, Michael A.
    Menendez, Mariano E.
    Pagani, Nicholas R.
    Puzzitiello, Richard N.
    Kavolus, Joseph J.
    JOURNAL OF ORTHOPAEDICS, 2021, 26 : 54 - 57
  • [35] Prevalence of Modifiable Surgical Site Infection Risk Factors in Hip and Knee Joint Arthroplasty Patients at an Urban Academic Hospital
    Pruzansky, Jason S.
    Bronson, Michael J.
    Grelsamer, Ronald P.
    Strauss, Elton
    Moucha, Calin S.
    JOURNAL OF ARTHROPLASTY, 2014, 29 (02) : 272 - 276
  • [36] Cementless One-Stage Revision in Chronic Periprosthetic Hip Joint Infection. Ninety-One Percent Infection Free Survival in 56 Patients at Minimum 2-Year Follow-Up
    Lange, Jeppe
    Troelsen, Anders
    Solgaard, Soren
    Otte, Kristian S.
    Jensen, Niels K.
    Soballe, Kjeld
    JOURNAL OF ARTHROPLASTY, 2018, 33 (04) : 1160 - +
  • [37] Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study
    Zong, Kaican
    Li, Wen
    Fu, Yingya
    Zhang, Sha
    Liu, Yi
    Li, Shiying
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [38] Commercial Synovial Antigen Testing is Inferior to Traditional Culture for the Diagnosis of Periprosthetic Joint Infection in Patients Undergoing Revision Total Knee Arthroplasty
    Tarabichi, Saad
    Johnson, Roseann M.
    Quinlan, Nicole D.
    Dennis, Douglas A.
    Parvizi, Javad
    Jennings, Jason M.
    JOURNAL OF ARTHROPLASTY, 2024, 39 (08) : S296 - S302
  • [39] Periprosthetic Joint Infection Is Associated with an Increased Risk of Venous Thromboembolism Following Revision Total Knee Replacement An Analysis of Administrative Discharge Data
    Bass, Anne R.
    Zhang, Yi
    Mehta, Bella
    Do, Huong T.
    Russell, Linda A.
    Sculco, Peter K.
    Goodman, Susan M.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2021, 103 (14) : 1312 - 1318
  • [40] What Factors Influence In-Hospital Mortality Following Aseptic Revision Total Hip Arthroplasty? A Single-Center Analysis of 13,203 Patients
    Karlidag, Taner
    Budin, Maximilian
    Luo, T. David
    Dasci, Mustafa Fatih
    Gehrke, Thorsten
    Citak, Mustafa
    JOURNAL OF ARTHROPLASTY, 2025, 40 (03) : 744 - 750